An Nguyen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
An Nguyen has a total of 66 co-authors. Here are the top co-authors by number of shared publications:
- Bao Ngoc Vu
PATH, Hanoi, Vietnam
2 shared publications Clint Pecenka
PATH
2 shared publications- Kimberly Elizabeth Green
APATH, Hanoi, Viet Nam
2 shared publications - Tran Hung Minh
Center for Creative Initiatives in Health and Population, Hanoi, Vietnam
2 shared publications - An Khanh Tran
PATH, Vietnam
1 shared publication An Tran Khanh
PATH, Hanoi, Vietnam
1 shared publication
Latest Publications
- Open Access
- 21 April 2026
- Published by Springer Nature in Malaria Journal
- Vol. 25 (1)
A framework for identifying cost efficiencies in malaria routine data quality audits: methodology and application in Zambia
Background: Routine data quality audits (RDQA) are a critical activity conducted by many country malaria programs to assess the reliability of reported malaria data, but it requires significant human and financial resources. In collaboration with the Zambia National Malaria Elimination Centre, PATH’s Malaria Control and Elimination Partnership in Africa (MACEPA) proposed a framework for identifying cost efficiencies in RDQAs. To demonstrate this approach, previously collected RDQA data from Zambia was used as a case study. Methods: A systematic, replicable framework to identify cost efficiencies in malaria RDQA interventions was developed by applying health economic evaluation principles and micro-costing methods. The framework consists of four sequential stages: (1) Conduct a costing analysis to estimate costs of the RDQA interventions by estimating financial and economic costs of all RDQA phases (planning, orientation, audit, feedback); (2) Identify cost drivers of RDQA interventions through comparative analysis of total costs, cost per health facility catchment area (HFCA), and proportional contribution of each cost category, activity, and phase across multiple RDQA interventions; (3) Develop resource-optimized scenarios by adopting the lowest-cost feasible practices; (4) Evaluation of cost-efficiency of scenarios using incremental cost per additional HFCA audited compared to the base-case implementation. Nine RDQA interventions implemented by four projects in Zambia (2022–2024) covering 10 provinces, 91 districts, and 1,189 HFCAs were evaluated. Results: The proposed framework estimated the average economic costs of $24,938 per intervention ($205 per HFCA), with personnel (64%) and transportation (25%) as primary cost drivers of RDQAs in Zambia. Optimized scenarios incorporating virtual orientation meetings, streamlined audit team composition, and harmonized allowances reduced total costs by 41%. Transition to digital RDQA tools projected additional savings of up to 52%. Conclusion: This structured four-stage framework provides a practical methodology for identifying substantial cost efficiencies in RDQA interventions while maintaining or expanding coverage and quality. The analysis has strong implications for policy makers, funders and implementers of malaria programs on optimizing resource utilization for maintaining high-quality routine malaria data. The approach can extend to other disease-specific interventions or analogous activities, such as supportive supervision visits, enabling more sustainable implementation in countries facing similar resource constraints in health programs.
- 21 April 2026
- Published by Springer Nature in Malaria Journal
- Vol. 25 (1)
Open AccessA framework for identifying cost efficiencies in malaria routine data quality audits: methodology and application in Zambia
Background: Routine data quality audits (RDQA) are a critical activity conducted by many country malaria programs to assess the reliability of reported malaria data, but it requires significant human and financial resources. In collaboration with the Zambia National Malaria Elimination Centre, PATH’s Malaria Control and Elimination Partnership in Africa (MACEPA) proposed a framework for identifying cost efficiencies in RDQAs. To demonstrate this approach, previously collected RDQA data from Zambia was used as a case study. Methods: A systematic, replicable framework to identify cost efficiencies in malaria RDQA interventions was developed by applying health economic evaluation principles and micro-costing methods. The framework consists of four sequential stages: (1) Conduct a costing analysis to estimate costs of the RDQA interventions by estimating financial and economic costs of all RDQA phases (planning, orientation, audit, feedback); (2) Identify cost drivers of RDQA interventions through comparative analysis of total costs, cost per health facility catchment area (HFCA), and proportional contribution of each cost category, activity, and phase across multiple RDQA interventions; (3) Develop resource-optimized scenarios by adopting the lowest-cost feasible practices; (4) Evaluation of cost-efficiency of scenarios using incremental cost per additional HFCA audited compared to the base-case implementation. Nine RDQA interventions implemented by four projects in Zambia (2022–2024) covering 10 provinces, 91 districts, and 1,189 HFCAs were evaluated. Results: The proposed framework estimated the average economic costs of $24,938 per intervention ($205 per HFCA), with personnel (64%) and transportation (25%) as primary cost drivers of RDQAs in Zambia. Optimized scenarios incorporating virtual orientation meetings, streamlined audit team composition, and harmonized allowances reduced total costs by 41%. Transition to digital RDQA tools projected additional savings of up to 52%. Conclusion: This structured four-stage framework provides a practical methodology for identifying substantial cost efficiencies in RDQA interventions while maintaining or expanding coverage and quality. The analysis has strong implications for policy makers, funders and implementers of malaria programs on optimizing resource utilization for maintaining high-quality routine malaria data. The approach can extend to other disease-specific interventions or analogous activities, such as supportive supervision visits, enabling more sustainable implementation in countries facing similar resource constraints in health programs.
- Open Access
Antibiotic Use Among Children Under Two Years With Respiratory Syncytial Virus Infection at Korle Bu Teaching Hospital, Ghana
Background: Respiratory syncytial virus (RSV) is a major cause of lower respiratory tract infections in children, often leading to hospitalisation in infants. In low-resource settings where routine RSV diagnostics are unavailable, clinical overlap with bacterial pneumonia frequently results in unnecessary antibiotic use, contributing to antimicrobial resistance. Objective: To evaluate the frequency and clinical determinants of antibiotic use among RSV-positive children under two years at a tertiary hospital in Ghana. Methods: This cross-sectional study was conducted from June to November 2023 at the Department of Child Health, Korle Bu Teaching Hospital. Children with acute respiratory illness were enrolled and tested for RSV using molecular point-of-care and reverse transcriptase-polymerase chain reaction methods. Antibiotic use and clinical characteristics were analysed among RSV-positive cases. Results: Of 128 children enrolled, 72 (56.2%) tested positive for RSV. Among these, 48 (66.7%) received antibiotics. Antibiotic use was significantly associated with markers of disease severity, including hypoxia (p = 0.009), tachypnea (p = 0.015), dyspnea (p < 0.001), and hospital admission (p < 0.001). Only 11 (23%) had suspected or confirmed bacterial co-infections. Conclusion: A substantial proportion of RSV-positive children received antibiotics. These findings underscore the importance of antimicrobial stewardship programs, rapid diagnostics, and preventive interventions, such as maternal RSV vaccination. Strengthening diagnostic capacity and clinical decision-making in pediatric care is crucial for reducing inappropriate antibiotic use and addressing antimicrobial resistance in low-resource settings.
Open AccessAntibiotic Use Among Children Under Two Years With Respiratory Syncytial Virus Infection at Korle Bu Teaching Hospital, Ghana
Background: Respiratory syncytial virus (RSV) is a major cause of lower respiratory tract infections in children, often leading to hospitalisation in infants. In low-resource settings where routine RSV diagnostics are unavailable, clinical overlap with bacterial pneumonia frequently results in unnecessary antibiotic use, contributing to antimicrobial resistance. Objective: To evaluate the frequency and clinical determinants of antibiotic use among RSV-positive children under two years at a tertiary hospital in Ghana. Methods: This cross-sectional study was conducted from June to November 2023 at the Department of Child Health, Korle Bu Teaching Hospital. Children with acute respiratory illness were enrolled and tested for RSV using molecular point-of-care and reverse transcriptase-polymerase chain reaction methods. Antibiotic use and clinical characteristics were analysed among RSV-positive cases. Results: Of 128 children enrolled, 72 (56.2%) tested positive for RSV. Among these, 48 (66.7%) received antibiotics. Antibiotic use was significantly associated with markers of disease severity, including hypoxia (p = 0.009), tachypnea (p = 0.015), dyspnea (p < 0.001), and hospital admission (p < 0.001). Only 11 (23%) had suspected or confirmed bacterial co-infections. Conclusion: A substantial proportion of RSV-positive children received antibiotics. These findings underscore the importance of antimicrobial stewardship programs, rapid diagnostics, and preventive interventions, such as maternal RSV vaccination. Strengthening diagnostic capacity and clinical decision-making in pediatric care is crucial for reducing inappropriate antibiotic use and addressing antimicrobial resistance in low-resource settings.
- Open Access
- 24 January 2026
- Published by Springer Nature in Research Square
A framework for identifying cost efficiencies in malaria routine data quality audits: methodology and application in Zambia
Background : Routine data quality audits (RDQA) are a critical activity conducted by many country malaria programs to assess the reliability of reported malaria data, but it requires significant human and financial resources. In collaboration with the Zambia National Malaria Elimination Centre, PATH's Malaria Control and Elimination Partnership in Africa (MACEPA) proposed a framework for identifying cost efficiencies in RDQAs. To demonstrate this approach, previously collected RDQA data from Zambia was used as a case study. Methods : A systematic, replicable framework to identify cost efficiencies in malaria RDQA interventions was developed by applying health economic evaluation principles and micro-costing methods. The framework consists of four sequential stages: (1) Conduct a costing analysis to estimate costs of the RDQA interventions by estimating financial and economic costs of all RDQA phases (planning, orientation, audit, feedback); (2) Identify cost drivers of RDQA interventions through comparative analysis of total costs, cost per health facility catchment area (HFCA), and proportional contribution of each cost category, activity, and phase across multiple RDQA interventions; (3) Develop resource-optimized scenarios by adopting the lowest-cost feasible practices; (4) Evaluation of cost-efficiency of scenarios using incremental cost per additional HFCA audited compared to the base-case implementation. Nine RDQA interventions implemented by four projects in Zambia (2022-2024) covering 10 provinces, 91 districts, and 1,189 HFCAs were evaluated. Results : The proposed framework estimated the average economic costs of $24,938 per intervention ($205 per HFCA), with personnel (64%) and transportation (25%) as primary cost drivers of RDQAs in Zambia. Optimized scenarios incorporating virtual orientation meetings, streamlined audit team composition, and harmonized allowances reduced total costs by 41%. Transition to digital RDQA tools projected additional savings of up to 52%. Conclusion : This structured four-stage framework provides a practical methodology for identifying substantial cost efficiencies in RDQA interventions while maintaining or expanding coverage and quality. The approach can extend to other disease-specific interventions or analogous activities, such as supportive supervision visits, enabling more sustainable implementation in countries facing similar resource constraints in health programs.
- 24 January 2026
- Published by Springer Nature in Research Square
Open AccessA framework for identifying cost efficiencies in malaria routine data quality audits: methodology and application in Zambia
Background : Routine data quality audits (RDQA) are a critical activity conducted by many country malaria programs to assess the reliability of reported malaria data, but it requires significant human and financial resources. In collaboration with the Zambia National Malaria Elimination Centre, PATH's Malaria Control and Elimination Partnership in Africa (MACEPA) proposed a framework for identifying cost efficiencies in RDQAs. To demonstrate this approach, previously collected RDQA data from Zambia was used as a case study. Methods : A systematic, replicable framework to identify cost efficiencies in malaria RDQA interventions was developed by applying health economic evaluation principles and micro-costing methods. The framework consists of four sequential stages: (1) Conduct a costing analysis to estimate costs of the RDQA interventions by estimating financial and economic costs of all RDQA phases (planning, orientation, audit, feedback); (2) Identify cost drivers of RDQA interventions through comparative analysis of total costs, cost per health facility catchment area (HFCA), and proportional contribution of each cost category, activity, and phase across multiple RDQA interventions; (3) Develop resource-optimized scenarios by adopting the lowest-cost feasible practices; (4) Evaluation of cost-efficiency of scenarios using incremental cost per additional HFCA audited compared to the base-case implementation. Nine RDQA interventions implemented by four projects in Zambia (2022-2024) covering 10 provinces, 91 districts, and 1,189 HFCAs were evaluated. Results : The proposed framework estimated the average economic costs of $24,938 per intervention ($205 per HFCA), with personnel (64%) and transportation (25%) as primary cost drivers of RDQAs in Zambia. Optimized scenarios incorporating virtual orientation meetings, streamlined audit team composition, and harmonized allowances reduced total costs by 41%. Transition to digital RDQA tools projected additional savings of up to 52%. Conclusion : This structured four-stage framework provides a practical methodology for identifying substantial cost efficiencies in RDQA interventions while maintaining or expanding coverage and quality. The approach can extend to other disease-specific interventions or analogous activities, such as supportive supervision visits, enabling more sustainable implementation in countries facing similar resource constraints in health programs.
- Open Access
- 3 November 2025
- Published by Public Library of Science (PLoS) in PLOS Global Public Health
- Vol. 5 (11) , e0005365
Evaluating effectiveness and comparative costs of hepatitis C virus self-testing service delivery models in Vietnam: A cross-sectional study
Hepatitis C virus self-testing (HCVST) has been shown to reach people who may not otherwise test. We conducted a cross-sectional survey to assess the effectiveness and costs of different HCVST distribution models among key populations (KPs) and people living with HIV (PLHIV) in Hanoi and Ho Chi Minh City, Vietnam, between September 2023 and April 2024. We engaged eight community-based organizations (CBOs) and 10 public and private clinics in offering HCVST using oral fluid-based HCV rapid antibody tests along with standard or provider-led HCV testing (HCVT). HCVST effectiveness was assessed by the proportion of first-time testers, HCV positivity yield, and linkage to care. Outcomes were stratified by distribution model (community, facility, online, secondary distribution) and compared to standard HCVT. Cost per HCV diagnosis was calculated in US dollars. Among 2,882 participants tested for HCV, 1,834 used HCVST and 1,048 used standard HCVT. HCVST users were more likely to be first-time testers compared to those opting for standard testing (67.6% vs. 59,1%; p < 0.001). The highest proportion of first-time testers was reached through secondary distribution (91.4%) and community distribution (83.8%). HCV positivity through HCVST was significantly lower at CBOs but similar at clinics compared to standard testing (11% vs. 16%; p < 0.01; 16.8% vs. 20.8%; p = 0.094). HCVST at CBOs and clinics was more costly than standard testing ($636 vs. $408 and $605 vs. $218). HCVST was still costlier at CBOs but cheaper at clinics compared to standard testing when kit costs decreased to $2 ($417 vs. $218 and $357 vs. $408). HCVST effectively reached people with HCV and more first-time testers, compared to standard testing among KPs and PLHIV. While current HCVST distribution approaches are costlier than standard testing, modest reductions in commodity costs could make services comparable to help achieve Vietnam’s HCV elimination goals and reach underserved populations.
- 3 November 2025
- Published by Public Library of Science (PLoS) in PLOS Global Public Health
- Vol. 5 (11) , e0005365
Open AccessEvaluating effectiveness and comparative costs of hepatitis C virus self-testing service delivery models in Vietnam: A cross-sectional study
Hepatitis C virus self-testing (HCVST) has been shown to reach people who may not otherwise test. We conducted a cross-sectional survey to assess the effectiveness and costs of different HCVST distribution models among key populations (KPs) and people living with HIV (PLHIV) in Hanoi and Ho Chi Minh City, Vietnam, between September 2023 and April 2024. We engaged eight community-based organizations (CBOs) and 10 public and private clinics in offering HCVST using oral fluid-based HCV rapid antibody tests along with standard or provider-led HCV testing (HCVT). HCVST effectiveness was assessed by the proportion of first-time testers, HCV positivity yield, and linkage to care. Outcomes were stratified by distribution model (community, facility, online, secondary distribution) and compared to standard HCVT. Cost per HCV diagnosis was calculated in US dollars. Among 2,882 participants tested for HCV, 1,834 used HCVST and 1,048 used standard HCVT. HCVST users were more likely to be first-time testers compared to those opting for standard testing (67.6% vs. 59,1%; p < 0.001). The highest proportion of first-time testers was reached through secondary distribution (91.4%) and community distribution (83.8%). HCV positivity through HCVST was significantly lower at CBOs but similar at clinics compared to standard testing (11% vs. 16%; p < 0.01; 16.8% vs. 20.8%; p = 0.094). HCVST at CBOs and clinics was more costly than standard testing ($636 vs. $408 and $605 vs. $218). HCVST was still costlier at CBOs but cheaper at clinics compared to standard testing when kit costs decreased to $2 ($417 vs. $218 and $357 vs. $408). HCVST effectively reached people with HCV and more first-time testers, compared to standard testing among KPs and PLHIV. While current HCVST distribution approaches are costlier than standard testing, modest reductions in commodity costs could make services comparable to help achieve Vietnam’s HCV elimination goals and reach underserved populations.
- Open Access
- 19 July 2024
- Published by MDPI AG in Preprints.org
Effectiveness of Hepatitis C Virus Self-Testing Service Delivery Models among People Who Inject Drugs: A Cross-Sectional Study in Vietnam
This study assesses the effectiveness of HCV self-testing (HCVST) distribution models compared to provider-led HCV testing (PL-HCVT), including the standard of care facility-based HCVT (SOC-HCVT) and community-based organization HCVT (CBO-HCVT) among people who inject drugs (PWID) in Vietnam. A cross-sectional study was conducted as part of a larger implementation science study in Hanoi and Ho Chi Minh City from September 2023 to April 2024. We engaged 8 CBOs and 10 public and private clinics in offering choice of HCVST through community-based and facility-based distribution, and secondary distribution), or PL-HCVT via SOC-HCVT and CBO-HCVT. Among 1,165 PWID, 693 opted for HCVST and 472 for PL-HCVT. The proportion of first-time testers was significantly higher in HIVST community-based and secondary distribution as well as CBO-HCVT compared to SOC-HCVT and facility-based HCVST (87.1%, 93.3% and 82.7% vs. 41.9% and 35.7%, respectively; p < 0.001). Overall, HCV seropositivity rate was lower in HCVST than PL-HCVT, however, higher in HCVST facility-based and community-based distribution compared to HCVST secondary distribution (28.1% and 20.4% vs. 5.7%, respectively). Community-based HCVST was most effective, followed by facility-based HCVST and secondary distribution. Our findings indicate that HCVST effectively reaches first-time testers and results in more people diagnosed and treated among PWID.
- 19 July 2024
- Published by MDPI AG in Preprints.org
Open AccessEffectiveness of Hepatitis C Virus Self-Testing Service Delivery Models among People Who Inject Drugs: A Cross-Sectional Study in Vietnam
This study assesses the effectiveness of HCV self-testing (HCVST) distribution models compared to provider-led HCV testing (PL-HCVT), including the standard of care facility-based HCVT (SOC-HCVT) and community-based organization HCVT (CBO-HCVT) among people who inject drugs (PWID) in Vietnam. A cross-sectional study was conducted as part of a larger implementation science study in Hanoi and Ho Chi Minh City from September 2023 to April 2024. We engaged 8 CBOs and 10 public and private clinics in offering choice of HCVST through community-based and facility-based distribution, and secondary distribution), or PL-HCVT via SOC-HCVT and CBO-HCVT. Among 1,165 PWID, 693 opted for HCVST and 472 for PL-HCVT. The proportion of first-time testers was significantly higher in HIVST community-based and secondary distribution as well as CBO-HCVT compared to SOC-HCVT and facility-based HCVST (87.1%, 93.3% and 82.7% vs. 41.9% and 35.7%, respectively; p < 0.001). Overall, HCV seropositivity rate was lower in HCVST than PL-HCVT, however, higher in HCVST facility-based and community-based distribution compared to HCVST secondary distribution (28.1% and 20.4% vs. 5.7%, respectively). Community-based HCVST was most effective, followed by facility-based HCVST and secondary distribution. Our findings indicate that HCVST effectively reaches first-time testers and results in more people diagnosed and treated among PWID.
- Open Access
- 13 June 2023
- Published by Public Library of Science (PLoS) in PLOS Global Public Health
- Vol. 3 (6) , e0001873
Estimating the cost of illness of acute Japanese encephalitis and sequelae care in Vietnam and Laos: A cross-sectional study
Background: Japanese encephalitis (JE) is a leading cause of acute encephalitis syndrome and resulting neurological disability in Asia and the Western Pacific. This study aims to estimate the cost of acute care, initial rehabilitation and sequelae care, in Vietnam and Laos. Methodology: We conducted a cross-sectional retrospective study using a micro-costing approach from the health system and household perspectives. Out-of-pocket direct medical and non-medical costs, indirect costs, and family impact were reported by patients and/or caregivers. Hospitalization costs were extracted from hospital charts. Acute costs covered expenditures from pre-hospital to follow-up visits while sequelae care costs were estimated from expenditures in the last 90 days. All costs are in 2021 US dollars. Principal findings: 242 patients in two major sentinel sites in the North and South of Vietnam and 65 patients in a central hospital in Vientiane, Laos, with laboratory-confirmed JE were recruited regardless of age, sex, and ethnicity. In Vietnam, the mean total cost was $3,371 per acute JE episode (median $2,071, standard error [SE] $464) while annual costs were $404 for initial sequelae care (median $0, SE $220) and $320 for long-term sequelae care (median $0, SE $108). In Laos, the mean hospitalization costs in acute stage were $2,005 (median $1,698, SE $279) and the mean annual costs were $2,317 (median $0, SE $2,233) for initial sequelae care and $89 (median $0, SE $57) for long-term sequelae care. In both countries, most patients did not seek care for their sequelae. Families perceived extreme impact from JE and 20% to 30% of households still had sustained debts years after acute JE. Conclusions: JE patients and families in Vietnam and Laos suffer extreme medical, economic, and social hardship. This has policy implications for improving JE prevention in these two JE-endemic countries.
- 13 June 2023
- Published by Public Library of Science (PLoS) in PLOS Global Public Health
- Vol. 3 (6) , e0001873
Open AccessEstimating the cost of illness of acute Japanese encephalitis and sequelae care in Vietnam and Laos: A cross-sectional study
Background: Japanese encephalitis (JE) is a leading cause of acute encephalitis syndrome and resulting neurological disability in Asia and the Western Pacific. This study aims to estimate the cost of acute care, initial rehabilitation and sequelae care, in Vietnam and Laos. Methodology: We conducted a cross-sectional retrospective study using a micro-costing approach from the health system and household perspectives. Out-of-pocket direct medical and non-medical costs, indirect costs, and family impact were reported by patients and/or caregivers. Hospitalization costs were extracted from hospital charts. Acute costs covered expenditures from pre-hospital to follow-up visits while sequelae care costs were estimated from expenditures in the last 90 days. All costs are in 2021 US dollars. Principal findings: 242 patients in two major sentinel sites in the North and South of Vietnam and 65 patients in a central hospital in Vientiane, Laos, with laboratory-confirmed JE were recruited regardless of age, sex, and ethnicity. In Vietnam, the mean total cost was $3,371 per acute JE episode (median $2,071, standard error [SE] $464) while annual costs were $404 for initial sequelae care (median $0, SE $220) and $320 for long-term sequelae care (median $0, SE $108). In Laos, the mean hospitalization costs in acute stage were $2,005 (median $1,698, SE $279) and the mean annual costs were $2,317 (median $0, SE $2,233) for initial sequelae care and $89 (median $0, SE $57) for long-term sequelae care. In both countries, most patients did not seek care for their sequelae. Families perceived extreme impact from JE and 20% to 30% of households still had sustained debts years after acute JE. Conclusions: JE patients and families in Vietnam and Laos suffer extreme medical, economic, and social hardship. This has policy implications for improving JE prevention in these two JE-endemic countries.